Drugwatch.com, LLC – Trademark Portfolio
Entity Type: 16
Drugwatch.com, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CN, DRUGWATCH, and CONSUMERNOTICE.ORG. The owner is based in Orlando, FL.
189 S. Orange Avenue, Suite 1620
Orlando, FL 32801
Showing of trademarks Trademarks
Trademark Classifications
Drugwatch.com, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Drugwatch.com, LLC have?
Drugwatch.com, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Drugwatch.com, LLC file in?
Drugwatch.com, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Drugwatch.com, LLC's most well-known trademarks?
Drugwatch.com, LLC's registered trademark portfolio includes well-known marks such as CN, DRUGWATCH, and CONSUMERNOTICE.ORG. These are among 3 currently registered trademarks in the portfolio.
What is Drugwatch.com, LLC's trademark registration success rate?
Drugwatch.com, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.